| Metric | FY 2025 | Prior Q | FY 2024 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Revenue | $31.2B | — | — | — | — |
| Op. Income | $7.0B | — | — | — | — |
| Gross Margin | 31.4% | — | — | — | — |
| Net Margin | 7.5% | — | — | — | — |
| EPS (Diluted) | $1.14 | — | — | — | — |
| Free Cash Flow | $4.5B | — | — | — | — |
| Item | Amount |
|---|---|
| REVENUE | $31.2B |
| Cost of Revenue | $21.4B |
| GROSS PROFIT | $9.8B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $2.9B |
| Other Expenses | $0 |
| Operating Expenses | $2.9B |
| Cost & Expenses | $24.3B |
| OPERATING INCOME | $7.0B |
| Interest Income | $0 |
| Interest Expense | $2.2B |
| Other Income/Expenses | -$2.0B |
| INCOME BEFORE TAX | $4.9B |
| Income Tax Expense | $1.5B |
| Net Income from Continuing Ops | $3.4B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2.4B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2.4B |
| D&A | $4.1B |
| EBIT | $7.0B |
| EBITDA | $11.0B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| REVENUE | $31.2B |
| Cost of Revenue | $21.4B |
| GROSS PROFIT | $9.8B |
| R&D Expenses | $0 |
| Selling & Marketing | $0 |
| General & Administrative | $0 |
| SG&A Expenses | $2.9B |
| Other Expenses | $0 |
| Operating Expenses | $2.9B |
| Cost & Expenses | $24.3B |
| OPERATING INCOME | $7.0B |
| Interest Income | $0 |
| Interest Expense | $2.2B |
| Other Income/Expenses | -$2.0B |
| INCOME BEFORE TAX | $4.9B |
| Income Tax Expense | $1.5B |
| Net Income from Continuing Ops | $3.4B |
| Net Income from Discontinued Ops | $0 |
| Other Adjustments | $0 |
| NET INCOME | $2.4B |
| Net Income Deductions | $0 |
| BOTTOM LINE NET INCOME | $2.4B |
| D&A | $4.1B |
| EBIT | $7.0B |
| EBITDA | $11.0B |
| EPS | $1 |
| EPS Diluted | $1 |
| Item | Amount |
|---|---|
| Net Income | $2.4B |
| Depreciation & Amortization | $4.1B |
| Stock-Based Compensation | $0 |
| Deferred Income Tax | $0 |
| Other Non-Cash Items | $1.1B |
| Change in Working Capital | -$383M |
| OPERATING CASH FLOW | $7.1B |
| Capital Expenditure | -$2.6B |
| Acquisitions (Net) | -$96M |
| Purchases of Investments | -$2M |
| Sales/Maturities of Investments | $591M |
| Other Investing Activities | $29M |
| NET CASH FROM INVESTING | -$5.2B |
| Net Debt Issuance | $838M |
| Common Stock Repurchased | -$5M |
| Common Dividends Paid | -$3.1B |
| Other Financing Activities | -$167M |
| NET CASH FROM FINANCING | -$2.4B |
| FREE CASH FLOW | $4.5B |
| Net Change in Cash | -$380M |
| Item | Amount |
|---|---|
| Cash & Equivalents | $3.0B |
| Short-Term Investments | $515M |
| Net Receivables | $8.2B |
| Inventory | $2.4B |
| Other Current Assets | $815M |
| TOTAL CURRENT ASSETS | $15.0B |
| PP&E (Net) | $30.0B |
| Goodwill | $1.3B |
| Intangible Assets | $3.9B |
| Long-Term Investments | $12.5B |
| Tax Assets | $2.9B |
| Other Non-Current Assets | $14.0B |
| TOTAL NON-CURRENT ASSETS | $64.6B |
| TOTAL ASSETS | $79.6B |
| Account Payables | $4.4B |
| Short-Term Debt | $2.8B |
| Deferred Revenue | $0 |
| Other Current Liabilities | $791M |
| TOTAL CURRENT LIABILITIES | $9.7B |
| Long-Term Debt | $27.6B |
| Deferred Revenue NC | $0 |
| Deferred Tax Liabilities | $3.3B |
| Other Non-Current Liabilities | $8.2B |
| TOTAL NON-CURRENT LIABILITIES | $39.3B |
| TOTAL LIABILITIES | $49.0B |
| Common Stock | $7.0B |
| Additional Paid-In Capital | $1.9B |
| Retained Earnings | $2.9B |
| Treasury Stock | $0 |
| Accum. Other Comp. Income | $11.7B |
| Other Equity | $1 |
| TOTAL STOCKHOLDERS' EQUITY | $23.5B |
| Minority Interest | $7.1B |
| TOTAL EQUITY | $30.6B |
| TOTAL LIABILITIES & EQUITY | $79.6B |
| Total Debt | $30.6B |
| Net Debt | $27.6B |
